Dissertatsia_DG_Semenikhina

291

670.Mason, J. B. Evaluation on the Concept of Non Specifity in Stress Theory / J. B. Mason // Journal of Psychiatric. Research. ― 1972. ― №8. ― P. 323―333.

671.McCabe, R. Explanatory Models of Illness in Schizophrenia: Comparison of

Four Ethnic Groups / R. McCabe, S. Priebe // Br. J. Psychiatry. ― 2004. ― Vol. 185. ― P. 25―30.

672. Mc Candless-Glimeher, L. Use of Symptoms by Schizophrenics to Monitor and

Redulate Their Illness / L. Mac Candless-Glimeher, Sh. McKnight, E. Hamera, B. K. Smith, K. A. Peterson, A. A. Plumlee // Hosp. Commun. Psychiatr. ― 1986.― Vol. 37.

― №9. ― P. 929―933.

673. McCue, R. E. Polypharmacy in Patients with Schizophrenia / R. E. McCue // J.

Clin. Psychiatry. ― 2003. ― Vol. 64. ― №9. ― P. 984―989.

674. Mc Fvoy, J. P. Measuring Chronic Schizophrenic Patient’s Attitudes toward their

Illness and Treatment / J. P. Mc Fvoy, J. Aland, W. H. Wilson, W. Guy, L. Hawkins // Hosp. Commun. Psychiatr. ― 1981. ― №12. ― P. 856―858.

675.	McKennо, A. M. Dual Diagnosis: Empirical and Developmental Approaches. / A.
M.	McKennо, A. Pоredes	// Recent Developments in Alcoholism. ― 1992. ― Vol.
10. ― P. 89―107.
676.	Meskanen, K. A	Randomized Clinical Trial of Histamine 2 Receptor

Antagonism in Treatment-Resistant Schizophrenia / K. Meskanen, H. Ekelund, J.

Laitinen, P. J. Neurvonen, J. Haukka, P. Panula, J. Ekelund // J. Clin. Psychopharm. ― 2013.― №7. ― P. 35―47.

677.Mignot, G. Acathisia and Neuroleptics /G. Mignot //Therapie. ― 1982. ―№1. ― S. 257―269.

678.Mitchell, A. J. Psychotropic Medication: is it a Form of Self-medication? / A. J.

Mitchell / /Medical Hypothesis. ― 2007. ― №68. ― P. 12―21.

679. Mönninger, K. Psychiatry and Medicine / K. Menninger // Bull. Menninger. Clin. ― 1986. ― №5. ― P. 419―427.

292

680. Morgan, C. J. Effects of cannabidiol on schizophrenia-like symptoms in people who use cannabis / C. J. Morgan, H. V. Curran // Br. J. Psychiatry. ― 2008. ― Vol. 192. №4. ― Р. 306―307.

681.Morgan, D. W. Schizophrenic Simptom Change with. Rehospitalisation / D. W. Morgan, R. J.Pozzio, J. L.Hedlund // Arch. Gen. Psychiatr. ― 1968. ― №2. ― P. 227―236.

682.Muesser, K. T. Prevalence of Substance Abuse in Schizophrenia, Demographic and Clinical Correlations / K. T. Muesser, P. R. Yarnold, D. F. Levenson // Schizophr.

Bull. ―1990. ― Vol. 16. ― P. 31―56.

683. Muesser, K. T. Social skin and domains of function / K. T. Muesser, A. S.

Bellock, R. L. Morisson, J. T. Wixted // J. Psychiatr. Res. ― 1990. ― Vol. 24. ― P. 51―63.

684. Mulholl, C. The symptoms of Depressions in Schizophrenia and its Management / C. Mulholl, S. Cooper // Advances in Psychiatric Treatment. ― 2000. ― Vol. 6. ― P. 169―177.

685. Mulsant, B. H. Low Use of Neuroleptic Drugs in the Treatment of Psychotic

Major Depression / B. H. Mulsant, R. F. Hoskett, J. Prudic // Amer. J. Psychiatry. ― 1997. ― Vol. 154. ― P. 559―561.

686. Murrau, J. B. Neuroleptic malignant syndrome / J. B. Murrau // J. Gen. Psychol.

― 1987. ― Vol. 114/ ― №1/ ― Р. 39―46.

687. Nuechterlein, K. H. The Vulnerability Stress Model of Schizophrenia Relapse: a Longitidunal Stydy / K. H. Nuechterlein, M. E. Pawson, J. Ventura // Acta Psyciatr.

Scand. ― 1994. ― №382. ― P. 58―64.

688.Noorbala, A. A. Piracetam in Treatment of Schizophrenia: Implications for the Glutamate Hypothesis of Schizophrenia / A. A. Noorbala, S. Akhondzaden, R. Davari-Ashriarri // Pharmacy and Therapeutics. ― 1999. ― Vol. 24. ― P. 369―374.

689.O'Keeffe S.T. Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome / S.T. O'Keeffe // Sleep Medicine. ― 2003. ― Vol. 4. ― №2. ― Р. 121―132.

293

690. Olmsted, T. R. Neuroleptic malignant syndrome cuadeliney for treatment and reirstitution of neuroleptics / T. R. Olmsted // Sonth. Med. J. ― 1988. ― №7. ― Р. 888―891.

691.Ondo W. Restless leg syndrome: clinico-etiological correlates / W. Ondo, J. Jankovic // Neurology. ―1996. ― Vol. 47. ― Р. 1435―1441.

692.Park, S. Spatial working memory deficits in the relatives of schizophrenic patients / S. Park, P. S. Holzman, P. S. Gldman-Rakic // Arch. Gen. Psychiatr. ― 1995. ― Vol. 52. ― Р. 824―828.

693.Parsons, T. Societies: Evolutionare and Comparative Perspectives / T. Parsons. ― Harvard: Harvard University Press, 1966. ― 417 p.

694.Patton, D. Personality Characteristics of Smokers and Ex-smokers / D. Patton,

G. Barnes, R Murray // Personality and Individual Differences. ― 1993. ― Vol. 15. ― P. 653―654.

695. Pendry, L. F. Stereotypes and Mental Life: the Case of the Motivated but Twarted

Tactican / L. F. Pendry, C. N. Macrac // Jornal of Experimental Social Psychology. ― 1990. ― Vol. 30. ― P. 303―325.

696. Perata, V. Influence of Cannabis Abuse in Schizophrenic Psychopathology / V.

Perata, M. J. Cuesta // Acta Psychiat. Scand. ― 1992. ― №2. ― P. 127―130.

697.Perrez, M. Stress, Coping, and Health. A Situation-Behavior Approach. Theory, Methods, Applications / M. Perrez, M. Reicherts. ― Seottle-Toronto-Bern-Gottingen : Hogref Huber Publishers, 1992. ― 217 p.

698.Peryngl, A. Apszichofarmakonok megvonasa utan kialaku to tunetegyuttesek / A.

Peryngl // Orv. hetilop. ― 1983. ― №18. ― S. 1073―1076.

699. Pfohl, B. The Evolution of Symptomps in Institutionalized Hebephrenic

Catatonic Schizophrenics / B. Pfohl, G. Winokur / /Brit J. Psychiatr. ― 1982. ― №12. ― P. 567―572.

700. Priebe, S. Does Routine Screening for Benzodiazepine Help to Diagnose Dependence in Psychiatric Inpatients / S. Priebe, O. Liesenfeld, B. Muller-

Derlinghausen // Acta Psychiatr. Scand. ― 1989. ― Vol. 80. ― №5. ― P. 514―517.

294

701. Piedmont, E. B. Revolutions in Psychiatry or the Emperor’s New Clothes / E. B.

Piedmont, K. J. Downey // J. Soc. Psychiatr. ― 1971. ― №2. ― P. 111―121.

702. Priest, R. G. Lay People’s Attitudes to Treatment of Depression: Results of

Opinion Poll for Defeat Depression Campaign Just before its Launch / R. G. Priest, G.

Visze, A. Robert // British Medical Journal. ― 1998. ― Vol. 313. ― P. 858―859.

703. Reinolds, G. P. Beyond the Dopamine Hypotesis. The Neurochemical Patology of

Schizophrenia / G. P. Reinolds // Brit. J. Psychiatry. ― 1989. ― Vol. 155. ― P. 305―316.

704. Robach, H. B. Psychotherapy and Confidence / H. B. Robach, M. Shelton // J.

Psychother. Prarct. ― 1995. ― №4. ― P. 185―193.

705. Roose, S. P. Compliance: the Impact of Adverse Events and Tolerability on the Physicians Treatment Decisions / S. P. Roose // European Neuropsychopharmacology.

― 2004. ― Vol. 13. ― P. 85―92.

706.Rossler, W. Бремя шизофрении и психотических расстройств в странах Евросоюза (расширенный реферат) / W. Rossler, H. J. Salize, J. van Os, A. RiecherRossler // Психиатрия и психофармакотерапия. ― 2006. ― №2. ― С. 53―57.

707.Rubino, I. A. Pereeptial Defense sand Self Rated Personality Disorders: a Multivariate Analisis / I. A. Rubino, V. Zanna, B. Fedeli // Recept. Mot. Skills. ―

1998. ― Vol. 86. ― P. 1203―1209.

708.Saarinen, S. Social Networks of dischogen schizophrenia patients: groops at risk / S. Saarinen, K. R. Salokandas, M. Ojanen // Poster presentation at the XIV World Congress of social psyctiatry, June 5-10, 1994 Hamburg, Cermany. ― 1994. ― P. 247―251.

709.Salter, M. The Stigma of Mental Illness now You Can Use the Media to Reduce /

M. Salter, P. Burne // Psychiatric Bulletin. ― 2000. ― Vol. 24. ― P. 281―283.

710. Scharfetter, C. Schizophren Menschen / C. Scharfetter. ― Munchen, 1990. ―

193 s.

	295
711. Scheier,	F. R. A review of psychoactive substance use and abuse in

schizophrenia. Partners of drug choise / F. R. Scheier, S. G. Siris // J. Nerv. Ment. Dis.

― 1987. ― №11. ― Р. 641―652.

712. Schiffman, J. Minor physical anomales and schizophrenia spectrum disorders: A Prospective investigation / J. Schiffman, M. Ekstron, J. L. A. Brie, F. Schulsinger, H.

Sorensen, S. Hednick // Amer. J. Psyciatry. ― 2002. ― Vol.159. ― P. 238―243.

713. Scott, K. M. Age patterns in the prevalence of DSM-IV depressive/anxiety disorders with and without physical co-morbidity / K. M. Scott , M. Von Korff, J.

Alonso // Psychol Med. ― 2008. ― Vol. 38. ― P. 1659―69.

714. Selye, H. History and Present Status of the Stress Concept // Goldberger and S

Preznits (Eds) Hand book of Stress Theoretical and clinical aspects. ― New-York : The

Free Press, 1986. ― 392 p.

715.Semple, D. M. Cannabis as a Risk Factor for Psychosis: Systematic Review / D. M. Semple, A. M. Melantosch, S. M. Lawrie // J. Psychopharmacol. ― 2005. ― Vol.

19.― P. 187―194.

716.Sheehan, W. Psychiatry Patient’s Belif in General Health Factors and Sin as Causes of Illness / W. Sheehan, J. Kroll // Amer. J. Psychiaty. ― 1990. ― №1.― P.

111―113.

717. Shorr, A. Gesundheit und Krankheit: zwei Begriffe mitgetrennter Historie? //,

Wie desung sind Kranke? / R. Lutz und N. Mark (Hrsg). ― Göttingen : Verland fur Angewoondte Psychologie, 1995. ― S. 53―69.

718. Sikora, J. Management of Neuroleptic Side-effects with Piracetam. /J. Sikora, J.

Kabes, J. Pisvejc // Ceskoslovenska Psychiatrie. ― 1981. ― Vol. 77. ― P. 137―142.

719. Simon, A. E. Prodromes of first episde psychosis: how can we cholenge non spificity / A. E.Simon, F. R. Ferrero, Mc. G. Merio // Comprehensive Psychiatry. ―

2001. ― №5. ― P. 382―385.

720. Sirus, S. G. Akinesia and Postpsychotic Depression a Difficult Differential

Diagnosis / S. G. Sirus // J. Clin. Psychiatry. ― 1987. ― №6. ― P. 240―243.

296

721. Sirus, S. G. Depression in Schizophrenia: Perspective in the Era of “Atypical”

Antypsychotic Agents / S. G. Sirus // Amer. J. Psychiatr. ― 2000. ― Vol. 157. ― P. 1379―1389.

722. Sirus, S. G. Depressive Symptoms in Schizophrenia / S.G. Sirus // Depression in Schizophrenia (ad. L.E.DeLisi). ― Washington : American Psychiatric Press, 1998. ― P. 3―23.

723. Sirus, S. G. Pharmacological Treatment of Substance Abusing Schizophrenia

Patients / S. G. Sirus // Schizophrenia Bull. ― 1990. ― Vol. 16. ― №1. ― P. 111―122.

724.Sirus, S. G. Postpsychotic Depressive Symptoms in Hospitalized Schizophrenic Patients / S. G. Sirus, G. K. Harmon, J. Endicott // Arch. Gener. Psychiatr. ― 1981. ―

№10. ― P. 1122―1123.

725.Small, J. Quetiapin in Patients with Schizophrenia / J. Small, S. Hirsch, L.

Arvanitis // Arch. Gen. Psychiatry. ― 1997. ― №54. ― Р. 549―557.

726. Spoont, M. R. Modulatory Role of Serotonin in Neuronal Information Processing:

Implication for Human Psychopathology / M. R. Spoont // Psychol. Bull. ― 1992. ― Vol. 112. ― №2. ― P. 330―350.

727. Stahl, N. N. We Can Agree after All! Achieving Consensus for a Critical Thinking Component of Gifted Program Using the Delphi Techniqe / N. N. Stahl, R. J.

Stahl // Rocper Rewiew. ― 1992. ― №2. ― P. 79―88.

728. Stimmel, G. L. Use of Benzodiazepines in Schizophrenia / G. L. Stimmel //

Psychopharmacotherapy. ― 1996. ― Vol. 16. ― P. 148―151.

729. Street, J. S. Long-term treatment-emergent dyskinetic symptomps in patients treated with olanzapine and haloperidol /J. S. Street, R. Tamura, T. Sander, G.

Tollefson // Amer. J. Psychiaty. ― Vol. 158. ― Р. 982―987.

730. Subbotnic, K. L. Depressive Symptoms in the Early Course of Schizophrenia: Relationship to Familial Psychiatric Illness / K. L. Subbotnic, K. N. Nuechterlein, R. W.

Azamow // Amer. J. Psychiatr. ― 1996. ― Vol. 54. ― P. 1551―1556.

297

731. Swartz, M. S. Violence and Hard Mental Disorder a Negative Role of Drug Dependance and Non-compliance / M. S. Swartz, J. W. Swanson, V. A. Hiday // Am. J.

Psychiatry. ― 1998. ― Vol. 155. ― P. 226―231.

732.Sziykowicz, J. K. Zmiana Osobovoski po pierwszej hospitalizocji u chorychna schizofrerie pzzewlekla / J. K. Szlykowich // Psychiat. Pol. ― 1977. ― №1. ― S. 43―50.

733.Tandon, R. Schizophrenia "Just the Facts": what we know in 2008 part 1:

overview / R. Tandon, M. S. Keshavan, H. A. Nasrallah // Schizophr. Res. ― 2008. ― Vol. 100. ― № 1―3. ― P. 4―19.

734. Tandor, R. Chlolinergic hyperactivity and negative schizophrenic symptoms. A model of cholinergic dopaminergic interactions in schizophrenia / R.Tandor, J. F.

Greden // Arch.Gen.Psychiatry. ― 1989. ― Vol. 46. ― №8. ― Р. 745―753.

735. Tardiff, K. Assaultive Behavior Chronic Inpatients and Aggressive Behaviors /

K. Tardiff, A. Sweillam // Psychiatry. ― 2000. ― Vol. 61. ― P. 123―128.

736. Tattan, T. Negative Symptomps of Schizophrenia and Compliance with

Medication / T. Tattan // Schizophrenia Bull. ― 2001. ― №1. ― Р. 149―155.

737. Thackrey, M. Patient Aggression against Clinical and Nonclinical Staff in V.A.

Medical Center / M. Thackey, R. G. Bobbitt // Hosp. Commun. Psychiatr. ― 1990. ― №2. ― P. 195―197.

738. Tilett, R. The Patient within − Psychopathology in the Helping Professions / R.

Tilett // Advances in Psychiatric Treatment. ― 2003. ― Vol. 9. ― P. 272―279.

739. Turjanski, N. Psychiatric side effects of medication: recent development / N.

Turjanski, G. G. Lloyd // Advances in Psychiatric Treatment. ― 2005. ― Vol. 11. ― Р.

58―70.

740. Uranova, N. A. Morphometrik Study of Synaptic Sizein Autopsied Prefrontal Cortex, Caudate Nucleus, and Substancia Nigra of Schizophrenics / N. A. Uranova, D.

D. Orlovskaya, N. S. Kolomeets // Schizophrenia Res. ― 1997. ― Vol.24. ― №1−2. ― P. 41―42.

298

741. Vaguera, A. C. Clinical Risk Following Abrupt and Gradual withdrawal of Maintance Neuroleptic Treatment / A. C. Vaguera, R. J. Baldessorini, J. M. Hegart //

Arch. Gen. Psychiatry. ― 1997. ― Vol. 54. ― P. 49―52.

742. Vaillant, G. E. An Empirically Validated Hierarchy of Defende Mechanisma / G. E.Vaillant, M. Bond, G.Vaillant // Apch. Gen. Psychiatr. ― 1986. ― Vol. 83. ― P. 786―794.

743. Van Putten, T. Akinetic depression in schizophrenia / T. Van Putten, P. May. //

Arh. of Gen. Psychiatr. ― 1978. ― Vol. 35. ― P. 1101―1107.

744. Van ’T Veer, J. The Social Construction of Psychiatric Stigma. Perspectives from the Public, Patients and Family Members / J. Van ’T Veer. ― Twente: Academisch proefschrift Universiteit Twente, 2007. ― 127 p.

745. Verghease, C. Problema and progress in the diagnosis and treatment of polidipsia and hyponatremia / C. Verghease, J. De Leon, R. C. Josiassen // Schizophr. Bull. ― 1996. ― Vol. 22. ― Р. 455―464.

746. Versland, A. Substance Abuse Administrations´ Attitudes Regarding

Psychological Functioning of Persons with Single Diagnosis Versus Severe Dual

Diagnosis / A. Versland, H. H. Rosenberg // J. Dual Diagn. ― 2008. ― Vol. 4, №2. ― P. 126―141.

747. Vougioukas, A. The stress Caused by the Mental Illnesses / A. Voujoukas //

Hellin iatr. ― 1969. ― №7. ― P. 813―820.

748. Waddington, J. L. Schizophrenia: Developremental Neuroseience and

Pathobiology / J. L. Waddington // Lancet. ― 1993. ― Vol. 341. ― P. 531―538.

749.Waryszak, Z. Symptomatology and Social Adjustment of Psychiatric Patients befor ahd after Hospitalization / Z. Waryszak // Soc. Psychiatr. ― 1982. ― №3. ― P. 149―154.

750.Weinberger, D. R. Disorganization of Prefrontal-hippocampal Connectivity in Schizophrenia: a PET Studies of Discordant MZ Twins / D. R. Weinberger, K. F. Berman, J. L. Ostrem, A. Avi-Dargnam, E. F. Torrey // Soc. Neusci Abstracts. ― 1993.

― Vol.19. ― P. 7.

299

751. Westermeyer, J. J. Course of Substance Abuse in Patients with and without

Schizophrenia / J. J. Westermeyer, T. D. Schneekloth // Amer. J. Diseases. ― 1999. ―

Vol. 6. ― №1. ― P. 55―64.

752.Williams, A. The Public’s Knowledge of Psychiatrists: Qwestionary, Survoy / A.Williams , A. Cheyne, S. Macdonald // Psychiatr. Bull. ― 2001. ― №11. ― P. 420―432.

753.Wirshing, D. A. Novel antipsychotics: comparision of weightgain liabilities / D. A. Wirshing , W. C. Wirshing, L. Kysar // J. Clin. Psychiatry. ― 1999. ― Vol. 60. ―

Р. 358―353.

754. Wolf, B. Benzodiazepine Abuse and Dependence in Psychiatric Inpatients / B.

Wolf, R. Crohmann, D. Bider, P. M. Brinner, E. Ruther // Pharmacopsychiatry. ― 1989. ― №2. ― P. 54―60.

755.Wolf, G. Community Attitudes to Mental Illness / G. Wolf, S. Pathare, J. Craig, T. Leff // Brit.J. Psychiatr. ― 1996. ― Vol. 168. ― P. 183―190.

756.Yazici, K. M. The effect of clozapine onglncosac metabolism / K. M.Yazici, T. Erbas, A. H. Yazici // Exp.Clin. Endocrinol Diabetes. ― 1998. ― Vol. 106. ― Р.

475―477.

757. Zaslove, M. O. How Psychiatric Hospitalization Help: Patient Views vs. Staff

Views / M. O. Zaslove, S. T. Underlerleider, M. C. Fuller // J. Nerv. Ment. Dis. ―

1966. ― Vol. 142. ― №6. ― P. 568―576.

758. Zimberg, S. A Dual Diagnosis Typology to Improve Diagnosis and Treatment of

Dual Disorder Patient / S. Zimberg // Journal of Psychoactive Drugs. ― 1999. ― №1. ― Р. 47―51.

759.Zisook, S. The hysterical Personality. 1. The Healthy Hysteric / S. Zisook, R. A. de Vaul // Brit. J. Med. Psychol. ― 1978/ ― Vol. 51. ― №4. ― P. 368―378.

760.Zöllner, H. M. Die Einstelluhg depressiver und Schizophrener Kranker zu ihrer Diagnoze / H. M. Zöllner // Nerverzt. ― 1997. ― №1. ― S. 28―32.

300

Приложение 1

№ истории болезни ___________________

Ф.И.О. больного ______________________________________

Диагноз психического заболевания

Длительность психического заболевания

______________________________________

Ведущий синдром _____________________

______________________________________

Диагноз соматического заболевания

______________________________________

______________________________________

Длительность соматического заболевания